Home Details
| Official Symbol of Gene | IL22 |
| Species | Homo sapiens |
| Entrez Gene ID | 14900 |
| Official Full Name | interleukin 22 |
| Also known as | TIFa; IL-21; IL-22; ILTIF; IL-TIF; IL-D110; zcyto18; TIFIL-23 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000127318 MIM:605330; AllianceGenome:HGNC:14900 |
| Map Location | 12q15 |
| Drug | G2013 |
| Interaction Type | inhibitor |
| Descent | N/A |
| Disease | MS |
| Pubmed ID | 32103523 |
| Year | 2020 |
| Title | Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosis |
| Result | the results show that G2013 is able to significantly reduce the gene expression of IL-22, AHR, RORC, and T-bet |
| Mechanism/pathway | he α-L-guluronic acid (G2013), is a novel immunosuppressive drug |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.